First I never said it would be $200/share. I just disagree with your assessment of the marketplace and that no new investors will invest. I've seen $17b, $20b, $22b market in 5 years from all types of sources. Google articles about robotic surgery in India for example, let alone other countries (ie Japan, UK, etc) and u will read about the rapid adoption of robotic surgery.
Anyone in healthcare knows the priority in robotics and it's just the tip of the iceberg.
I'd be happy to have this stock hit $3 by end of q4, hit $8-10 by q4 2016/q1 2017 (outside U.S. Commercializations) and from then on its all gravy.